Product Code: GVR-1-68038-001-9
Extracorporeal Membrane Oxygenation Machine Market Growth & Trends:
The global extracorporeal membrane oxygenation machine market size is expected to reach USD 398.6 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The market is primarily driven by the increasing incidence of cardiopulmonary and respiratory diseases and technological advancement in the field of ECMO procedures. Cardiovascular disease is one of the leading causes of death globally.
According to the WHO, 17.9 million people died from cardiovascular diseases in 2016. In addition, according to the Extracorporeal Life Support Organization, a total of 45,035 patients globally suffered from respiratory illnesses in 2016. Furthermore, increasing awareness about ECMO procedures, coupled with various government initiatives, is further propelling the growth.
The increasing survival rate of ECMO machine supported surgery for cardiac and respiratory patients is also augmenting the market growth. Applications of ECMO machine procedures have been increased over the years. ECMO machine was traditionally used in cases of circulatory or respiratory failure. Its applications have expanded to use as rescue therapy for post-organ transplantation and sepsis and in cases of heart failure.
The ECMO machine use has been rising gradually worldwide owing to its benefits such as artificial lung for the patients and growing awareness about its use. Moreover, increasing healthcare expenditure by government and private agencies in order to improve healthcare facilities is adding growth to the market. According to the American Heart Association, medical expenditure related to CVDs is expected to reach USD 960 billion by 2030 from USD 320 billion in 2011. Major players in the market are focusing on technological collaboration and product launches.
Extracorporeal Membrane Oxygenation Machine Market Report Highlights:
- North America accounted for the largest share in 2020 owing to favorable reimbursement policies, the presence of key players, and government initiatives
- By component, the oxygenator segment accounted for the largest share in 2020 owing to its high cost and usage
- In terms of modality, the veno-arterial segment accounted for the largest share in 2020 and is expected to grow at the fastest rate during the forecast period
- Based on patient type, the adult segment is expected to grow at a rapid pace during the forecast period owing to the rising incidence of cardiac and pulmonary diseases
- On the basis of application, the respiratory segment held the largest market share in 2020 and is expected to grow at the fastest rate over the forecast period
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Component
- 1.1.2. Modality
- 1.1.3. Patient Type
- 1.1.4. Application
- 1.1.5. Region
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Component outlook
- 2.2.2. Modality outlook
- 2.2.3. Patient type outlook
- 2.2.4. Application outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. ECMO Machine Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rising prevalence of cardiopulmonary and respiratory diseases
- 3.4.1.2. Increasing adoption of ECMO machines in hospitals
- 3.4.1.3. Technological advancement in ECMO machines
- 3.4.1.4. Growing awareness towards the application of ECMO
- 3.4.2. Market restraint analysis
- 3.4.2.1. High cost of procedures
- 3.4.2.2. Risk of complications during ECMO procedures
- 3.4.2.3. Presence of conventional technique
- 3.4.3. Industry challenges
- 3.5. ECMO Machine Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major deals & strategic alliances analysis
- 3.5.4. Market entry strategies
Chapter 4. ECMO Machine Market: Component Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Pumps
- 4.1.2. Oxygenator
- 4.1.3. Controllers
- 4.1.4. Cannula
- 4.1.5. Accessories
- 4.2. Component Market Share, 2020 & 2028
- 4.3. Segment Dashboard
- 4.4. Global ECMO Machine Market by Component Outlook
- 4.4.1. Pumps
- 4.4.1.1. Pump market estimates and forecast, 2016 - 2028 (USD Million)
- 4.4.2. Oxygenator
- 4.4.2.1. Oxygenator market estimates and forecast, 2016 - 2028 (USD Million)
- 4.4.3. Controllers
- 4.4.3.1. Controllers market estimates and forecast, 2016 - 2028 (USD Million)
- 4.4.4. Cannula
- 4.4.4.1. Cannula market estimates and forecast, 2016 - 2028 (USD Million)
- 4.4.5. Accessories
- 4.4.5.1. Accessories market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 5. ECMO Machine Market: Modality Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Veno-Arterial
- 5.1.2. Veno-Venous
- 5.1.3. Arterio-Venous
- 5.2. Modality Market Share, 2020 & 2028
- 5.3. Segment Dashboard
- 5.4. Global ECMO Machine Market by Modality Outlook
- 5.4.1. Veno-Arterial
- 5.4.1.1. Veno-Arterial market estimates and forecast, 2016 - 2028 (USD Million)
- 5.4.2. Veno-Venous
- 5.4.2.1. Veno-Venous market estimates and forecast, 2016 - 2028 (USD Million)
- 5.4.3. Arterio-Venous
- 5.4.3.1. Arterio-Venous market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 6. ECMO Machine Market: Patient Type Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Neonates
- 6.1.2. Pediatric
- 6.1.3. Adult
- 6.2. Patient Type Market Share, 2020 & 2028
- 6.3. Segment Dashboard
- 6.4. Global ECMO machine market by Patient Type Outlook
- 6.4.1. Neonates
- 6.4.1.1. Neonates market estimates and forecast, 2016 - 2028 (USD Million)
- 6.4.2. Pediatric
- 6.4.2.1. Pediatric market estimates and forecast, 2016 - 2028 (USD Million)
- 6.4.3. Adult
- 6.4.3.1. Adult market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 7. ECMO Machine Market: Application Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.1.1. Respiratory
- 7.1.2. Cardiac
- 7.1.3. ECPR
- 7.2. Application Market Share, 2020 & 2028
- 7.3. Segment Dashboard
- 7.4. Global ECMO machine Market by Application Outlook
- 7.4.1. Respiratory
- 7.4.1.1. Respiratory market estimates and forecast, 2016 - 2028 (USD Million)
- 7.4.1.2. Respiratory market estimates and forecast, by patient type 2016 - 2028 (USD Million)
- 7.4.1.2.1. Neonates
- 7.4.1.2.2. Pediatric
- 7.4.1.2.3. Adult
- 7.4.2. Cardiac
- 7.4.2.1. Cardiac market estimates and forecast, 2016 - 2028 (USD Million)
- 7.4.2.2. Cardiac market estimates and forecast, by patient type 2016 - 2028 (USD Million)
- 7.4.2.2.1. Neonates
- 7.4.2.2.2. Pediatric
- 7.4.2.2.3. Adult
- 7.4.3. ECPR
- 7.4.3.1. ECPR market estimates and forecast, 2016 - 2028 (USD Million)
- 7.4.3.2. ECPR market estimates and forecast, by patient type 2016 - 2028 (USD Million)
- 7.4.3.2.1. Neonates
- 7.4.3.2.2. Pediatric
- 7.4.3.2.3. Adult
Chapter 8. ECMO Machine Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2020 & 2028
- 8.2. Regional Market Dashboard
- 8.3. Regional Market Snapshot
- 8.4. Regional Market Share and Leading Players, 2020
- 8.4.1. North America
- 8.4.2. Europe
- 8.4.3. Asia Pacific
- 8.4.4. Latin America
- 8.4.5. Middle East and Africa
- 8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 8.5.1. North America
- 8.5.2. Europe
- 8.5.3. Asia Pacific
- 8.5.4. Latin America
- 8.5.5. Middle East and Africa
- 8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 to 2028:
- 8.7. North America
- 8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 8.7.2. U.S.
- 8.7.2.1. U.S. market estimates and forecast, 2016 - 2028 (USD Million)
- 8.7.3. Canada
- 8.7.3.1. Canada market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8. Europe
- 8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.2. U.K.
- 8.8.2.1. U.K. market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.3. Germany
- 8.8.3.1. Germany market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.4. France
- 8.8.4.1. France market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.5. Italy
- 8.8.5.1. Italy market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.6. Spain
- 8.8.6.1. Spain market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.7. Czech Republic
- 8.8.7.1. Czech Republic market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.8. Russia
- 8.8.8.1. Russia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.9. Poland
- 8.8.9.1. Poland market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.10. Turkey
- 8.8.10.1. Turkey market estimates and forecast, 2016 - 2028 (USD Million)
- 8.8.11. Switzerland
- 8.8.11.1. Switzerland market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9. Asia Pacific
- 8.9.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.2. Japan
- 8.9.2.1. Japan market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.3. China
- 8.9.3.1. China market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.4. India
- 8.9.4.1. India market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.5. Australia
- 8.9.5.1. Australia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.6. South Korea
- 8.9.6.1. South Korea market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.7. Vietnam
- 8.9.7.1. Vietnam market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.8. Philippines
- 8.9.8.1. Philippines market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.9. Malaysia
- 8.9.9.1. Malaysia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.10. Indonesia
- 8.9.10.1. Indonesia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.9.11. Thailand
- 8.9.11.1. Thailand market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10. Latin America
- 8.10.1. market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10.2. Brazil
- 8.10.2.1. Brazil market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10.3. Mexico
- 8.10.3.1. Mexico market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10.4. Colombia
- 8.10.4.1. Colombia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10.5. Argentina
- 8.10.5.1. Argentina market estimates and forecast, 2016 - 2028 (USD Million)
- 8.10.6. Chile
- 8.10.6.1. Chile market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11. Middle East & Africa
- 8.11.1. Market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11.2. South Africa
- 8.11.2.1. South Africa market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11.3. Saudi Arabia
- 8.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11.4. UAE
- 8.11.4.1. UAE market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11.5. Oman
- 8.11.5.1. Oman market estimates and forecast, 2016 - 2028 (USD Million)
- 8.11.6. Kuwait
- 8.11.6.1. Kuwait market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2020
- 9.3.4. Medtronic Plc
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Procedure benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Maquet Holding
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Procedure benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. Microport Scientific Corporation
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Procedure benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. Terumo Cardiovascular System Corporation
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Procedure benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Medos Medizintechnik
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Procedure benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. Nipro Medical Corporation
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Procedure benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. LivaNova PLC
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Procedure benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. CytoSorbents Corporation
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Procedure benchmarking
- 9.3.11.4. Strategic initiatives
- 9.3.12. EUROSETS S.R.L
- 9.3.12.1. Company overview
- 9.3.12.2. Financial performance
- 9.3.12.3. Procedure benchmarking
- 9.3.12.4. Strategic initiatives